US FTC says AbbVie, Teva broke law in reaching AndroGel agreement
September 08, 2014 at 12:44 PM EDT
WASHINGTON, Sept 8 (Reuters) - Drug companies AbbVie Inc and Teva Pharmaceuticals Industries Ltd were sued by the U.S. Federal Trade Commission on Monday for allegedly illegally preventing generic production of AndroGel, used by men with low testosterone.
